Karen Anbro Gammeltoft

Karen Anbro Gammeltoft

PhD Student


Publication year:
  1. 2023
  2. Published
  3. Published
  4. 2022
  5. Published

    Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system

    Zhou, Y., Gammeltoft, Karen Anbro, Ryberg, Line Abildgaard, Pham, Long, Tjørnelund, H. D., Binderup, A., Duarte Hernandez, Carlos Rene, Fernandez-Antunez, C., Offersgaard, Anna Falden, Fahnøe, Ulrik, Peters, G. H. J., Ramirez Almeida, Santseharay, Bukh, Jens & Gottwein, Judith Margarete, 2022, In: Science Advances. 8, 51, eadd7197.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. 2021
  7. Published
  8. Published

    Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 in Vitro

    Gammeltoft, Karen Anbro, Zhou, Y., Duarte Hernandez, C. R., Galli, Andrea, Offersgaard, Anna Falden, Costa, Rui, Pham, Long, Fahnøe, Ulrik, Feng, S., Scheel, Troels Kasper Høyer, Ramirez Almeida, Santseharay, Bukh, Jens & Gottwein, Judith Margarete, 2021, In: Antimicrobial Agents and Chemotherapy. 65, 9, e02680-20.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

    Zhou, Y., Gilmore, K., Ramirez Almeida, Santseharay, Settels, E., Gammeltoft, Karen Anbro, Pham, Long, Fahnøe, Ulrik, Feng, S., Offersgaard, Anna Falden, Trimpert, J., Bukh, Jens, Osterrieder, K., Gottwein, Judith Margarete & Seeberger, P. H., 2021, In: Scientific Reports. 11, 14571.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 249460310